Astec Lifesciences Share Price
Start SIP in Astec Lifesciences
Start SIPAstec Lifesciences Performance
Day Range
- Low 1,245
- High 1,284
52 Week Range
- Low 825
- High 1,474
- Open Price1,281
- Previous Close1,262
- Volume33319
Astec Lifesciences Investment Rating
-
Master Rating:
-
Astec Lifesciences has an operating revenue of Rs. 384.70 Cr. on a trailing 12-month basis. An annual revenue de-growth of -28% needs improvement, Pre-tax margin of -13% needs improvement, ROE of -12% is poor and needs improvement. The company has a debt to equity of 54%, which is bit higher. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 9% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 12 which is a POOR score indicating inconsistency in earnings, a RS Rating of 25 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 47 indicates it belongs to a fair industry group of Chemicals-Agricultural and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 69 | 154 | 51 | 111 | 143 | 127 |
| Operating Expenses Qtr Cr | 116 | 141 | 69 | 114 | 140 | 122 |
| Operating Profit Qtr Cr | -46 | 13 | -18 | -3 | 3 | 5 |
| Depreciation Qtr Cr | 9 | 9 | 9 | 9 | 9 | 8 |
| Interest Qtr Cr | 7 | 7 | 6 | 6 | 6 | 6 |
| Tax Qtr Cr | -22 | 0 | -8 | -4 | -3 | -1 |
| Net Profit Qtr Cr | -40 | -1 | -24 | -13 | -8 | -5 |
Astec Lifesciences Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹1,219.86
- 50 Day
- ₹1,228.00
- 100 Day
- ₹1,218.52
- 200 Day
- ₹1,216.86
- 20 Day
- ₹1,215.24
- 50 Day
- ₹1,243.49
- 100 Day
- ₹1,233.92
- 200 Day
- ₹1,147.93
Astec Lifesciences Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 1,284.27 |
| Second Resistance | 1,303.58 |
| Third Resistance | 1,323.22 |
| RSI | 62.10 |
| MFI | 76.11 |
| MACD Single Line | -7.16 |
| MACD | 1.13 |
| Support | |
|---|---|
| First Support | 1,245.32 |
| Second Support | 1,225.68 |
| Third Supoort | 1,206.37 |
Astec Lifesciences Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 34,701 | 1,839,153 | 53 |
| Week | 41,517 | 1,967,925 | 47.4 |
| 1 Month | 28,677 | 1,573,776 | 54.88 |
| 6 Month | 67,122 | 3,546,056 | 52.83 |
Astec Lifesciences Result Highlights
Astec Lifesciences Synopsis
NSE-Chemicals-Agricultural
Astec Lifesciences L is involved in the business activities of Manufacture of insecticides, rodenticides, fungicides, herbicides. Company’s Total Operating Revenue is Rs. 458.18 Cr. and Equity Capital is Rs. 19.61 Cr. for the Year ended 31/03/2024. Astec Lifesciences Ltd. is a Public Limited Listed company incorporated on 25/01/1994 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1994PLC076236 and registration number is 076236.| Market Cap | 2,476 |
| Sales | 385 |
| Shares in Float | 0.65 |
| No of funds | 28 |
| Yield | 0.25 |
| Book Value | 6.71 |
| U/D Vol ratio | 0.5 |
| LTDebt / Equity | 54 |
| Alpha | -0.09 |
| Beta | 0.64 |
Astec Lifesciences Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 66.75% | 66.75% | 66.75% | 66.75% |
| Mutual Funds | 3.04% | 7.79% | 8.77% | 9.15% |
| Foreign Portfolio Investors | 1.03% | 1.25% | 1.28% | 1.33% |
| Financial Institutions/ Banks | ||||
| Individual Investors | 22.52% | 19.63% | 18.19% | 17.9% |
| Others | 6.66% | 4.58% | 5.01% | 4.87% |
Astec Lifesciences Management
| Name | Designation |
|---|---|
| Mr. Nadir B Godrej | Chairman |
| Mr. Ashok V Hiremath | Non Executive Director |
| Mr. Balram Singh Yadav | Non Executive Director |
| Mr. Anurag Roy | Director |
| Dr. Brahma Nand Vyas | Independent Director |
| Mr. R R Govindan | Independent Director |
| Mr. Nandkumar Dhekne | Independent Director |
| Ms. Anjali Gupte | Independent Director |
| Mr. Burjis Nadir Godrej | Non Executive Director |
Astec Lifesciences Forecast
Price Estimates
Astec Lifesciences Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-07-29 | Quarterly Results | |
| 2024-05-02 | Audited Results | |
| 2024-01-25 | Quarterly Results | |
| 2023-10-27 | Quarterly Results & Others | |
| 2023-07-27 | Quarterly Results |
Astec Lifesciences FAQs
What is Share Price of Astec Lifesciences ?
Astec Lifesciences share price is ₹1,264 As on 18 September, 2024 | 02:25
What is the Market Cap of Astec Lifesciences ?
The Market Cap of Astec Lifesciences is ₹2480.7 Cr As on 18 September, 2024 | 02:25
What is the P/E ratio of Astec Lifesciences ?
The P/E ratio of Astec Lifesciences is -31.6 As on 18 September, 2024 | 02:25
What is the PB ratio of Astec Lifesciences ?
The PB ratio of Astec Lifesciences is 6.7 As on 18 September, 2024 | 02:25